To save researchers time and resources, The Michael J. Fox Foundation has made a number of tools available to the scientific community at low cost, with rapid delivery.
Helpful Resources
-
Sponsored Tools Program
Learn more about how MJFF can help share your tools.
-
Tools Consortium
MJFF is working with industry to develop priority tools.
-
Preclinical Models
Learn more about the various in vivo models used in Parkinson's disease research.
Find a Research Tool
Filter by Tool Type or Gene/Protein Type to Organize Results
* = MJFF does not control pricing or terms of availability for this tool.
Filters
SPTSSB Antibody
Antibody
Rabbit monoclonal antibody directed against human SPTSSB. Developed for use in immunoblotting, immunocytochemistry, and immunoprecipitation applications. This antibody development project is part of the Aligning Science Across Parkinson’s (ASAP) Initiative. Anticipated Availability: Q4 2027
Trpml1 Knockout RAW264.7 Cell Line
Immortalized Cell
RAW264.7 cell line with homozygous knockout of Trpml1. This cell line development project is part of the MJFF Targets to Therapies (T2T) Initiative. Anticipated Availability: Q4 2026
NOD2 Knockout MCF-7 Cell Line
Immortalized Cell
MCF-7 cell line with homozygous knockout of NOD2. This cell line development project is part of the MJFF Targets to Therapies (T2T) Initiative. Anticipated Availability: Q4 2026
Nod2 Knockout RAW264.7 Cell Line
Immortalized Cell
RAW264.7 cell line with homozygous knockout of Nod2. This cell line development project is part of the MJFF Targets to Therapies (T2T) Initiative. Anticipated Availability: Q4 2026
TRPM2 Antibody
Antibody
Rabbit monoclonal antibody directed against human TRPM2. Developed for use in immunoblotting, immunocytochemistry, and immunoprecipitation applications. This antibody development project is part of the Aligning Science Across Parkinson’s (ASAP) Initiative. Anticipated Availability: Q4 2027
ASAH1 Knockout A549 Cell Line
Immortalized Cell
A549 cell with homozygous knockout of ASAH1. Estimated Availability: Late 2025
DELE1 Knockout A-375 Cell Line
Immortalized Cell
A-375 cell line with homozygous knockout of DELE1. Anticipated Availability: Q4 2026
Dele1 Knockout RAW264.7 Cell Line
Immortalized Cell
RAW264.7 cell line with homozygous knockout of Dele1. Anticipated Availability: Q4 2026
DYRK1A Antibody
Antibody
Rabbit monoclonal antibody directed against human/mouse DYRK1A. Developed for use in immunoblotting, immunocytochemistry, immunohistochemistry, and immunoprecipitation applications. This antibody development project is part of the Aligning Science Across Parkinson’s (ASAP) Initiative. Anticipated Availability: Q4 2027
SLC18B1 Knockout HCT-116 Cell Line
Immortalized Cell
HCT-116 cell line with homozygous knockout of SLC18B1. This cell line development project is part of the Aligning Science Across Parkinson’s (ASAP) Initiative. Anticipated Availability: Q4 2026
Have questions or need additional information?
Email tools@michaeljfox.org with questions and to suggest new tools for us to develop. Or visit our FAQ page.
"We have shown, thanks in part to MJFF, that researchers now have in their pantry the right ‘ingredients’, to... help to drive forward PD drug development.”
Heather Melrose, PhD
Mayo Clinic